SCHEMBL6421168

SCHEMBL6421168

CC(=O)OC(=O)Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.59
HSD17B10 Q99714 1/20 0.59
SMN1; SMN2 Q16637 5/20 0.53
MAPT P10636 3/20 0.53
GAA P10253 3/20 0.53
ALDH1A1 P00352 2/20 0.53
HTT P42858 2/20 0.53
EPHX1 P07099 2/20 0.52
TP53 P04637 1/20 0.52
TSHR P16473 1/20 0.52
EPHX2 P34913 1/20 0.52
CDK9 P50750 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
RAB9A P51151 3/20 0.52
NPC1 O15118 2/20 0.52
TAAR1 Q96RJ0 2/20 0.52
KMT2A Q03164 1/20 0.52
POLB P06746 1/20 0.52
HPGD P15428 1/20 0.50
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002669 0.88 NAPRT (0.59) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL2244779 0.87 SMN1; SMN2 (0.61) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL12606901 0.84 NAPRT (0.55) NAPRTHSD17B10SMN1; SMN2MAPTGAA
Acetanilide SCHEMBL2652784 0.83 NAPRT (0.79) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL28216490 0.82 HSD17B10 (0.52) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL282531 0.80 SMN1; SMN2 (0.71) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL15638381 0.80 RAB9A (0.54) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL28049155 0.80 NPC1 (0.59) HSD17B10SMN1; SMN2MAPTGAAALDH1A1
SCHEMBL23240942 0.79 SMN1; SMN2 (0.52) NAPRTHSD17B10SMN1; SMN2MAPTGAA
SCHEMBL9065932 0.79 SMN1; SMN2 (0.52) NAPRTHSD17B10SMN1; SMN2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926264-B2 Phenylcarbamate derivatives as formyl peptide receptor modulators ALLERGAN, INC. (US) 2018-03-27 US disclosed
EP-3071548-B1 PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS ALLERGAN INC (US) 2017-11-08 EP disclosed
EP-3071548-A1 PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2016-09-28 EP disclosed
US-20160272581-A1 PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2016-09-22 US disclosed
US-9431649-B2 Coated electroactive materials UCHICAGO ARGONNE, LLC (US) 2016-08-30 US disclosed
WO-2015077451-A1 PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2015-05-28 WO disclosed
US-20110121240-A1 COATED ELECTROACTIVE MATERIALS UCHICAGO ARGONNE, LLC 2011-05-26 US disclosed
US-20050045064-A1 Cellulose acylate film for optical use, and producing method thereof FUJI PHOTO FILM CO., LTD. (JP) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272581-A1 PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS FPR2, FPR1, FPR3 NAPRT 583/4885HSD17B10 3586/4885SMN1; SMN2 4322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.